Cocrystal Pharma down on 1-for-12 reverse stock split plan

Cocrystal Pharma

04/10/2022 14:06

** U.S.-listed shares of Cocrystal Pharma Inc  COCP.O  fall
~8% to $0.28 premarket
    ** Co late on Monday said it had approved a 1-for-12 reverse
stock split of its common stock  urn:newsml:reuters.com:*:nGNXbBjGlP
    ** Co's shares expected to begin trading on split-adjusted
basis at start of trading on Oct. 11
    ** Says reverse stock split will support maintenance of co's
Nasdaq Capital Market's listing
    ** Reverse share split to reduce number of shares of
Cocrystal's common stock outstanding from ~97.5 mln shares to
~8.1 mln shares
    ** As of last close, stock down ~54% YTD
 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))